Non-Invasive Drug Delivery to Treat Posterior Uveitis

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$133,202.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43EY014772-01A2
Agency Tracking Number:
EY014772
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
ACIONT, INC.
ACIONT, INC., 350 WEST 800 NORTH, STE 250, SALT LAKE CITY, UT, 84103
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DAVID Miller
(801) 359-3461
DMILLER@ACIONT.COM
Business Contact:
JOHN HIGUCHI
(801) 359-3461
JWH@ACIONT.COM
Research Institution:
n/a
Abstract
Intermediate and posterior uveitis cause 10% of blindness in the U.S. The mainstay of therapy is to eradicate the infectious cause and to quell the inflammation with corticosteroids or immunosuppressants. Delivery of anti-inflammatory drugs to the posteri

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government